Objectives: This study aims to evaluate the well-being of patients with main duct intraductal papillary mucinous neoplasms (MD-IPMNs) or mixed type IPMNs (mixed-IPMNs) of the pancreas.
I
ntraductal papillary mucinous neoplasms (IPMNs) of the pancreas are cystic neoplasms, and, to date, 3 different forms have been recognized: main duct IPMNs (MD-IPMNs), branch duct IPMNs (BD-IPMNs), and mixed type IPMNs (mixed-IPMNs), depending on the location of the ductal lesion, which can be situated in the main pancreatic duct, in the secondary pancreatic ducts, or in both the pancreatic and the secondary ducts, respectively. 1 In a consecutive series of 101 patients, we have recently reported that BD-IPMNs do not change the quality of life (QoL) of affected patients 2 ; in addition, the prevalence of psychiatric disorders among patients with IPMN, a potential source of these disorders (alcohol misuse, age), has not been reported. Finally, there are no specific questionnaires for the evaluation of the QoL of patients with IPMNs and general questionnaires for assessing the well-being and psychiatric disorders of patients having BD-IPMNs type I have previously been validated. Thus, the aim of this observational study was to prospectively evaluate the 2-year follow-up results in a group of patients having MD-IPMNs or mixed-IPMNs to assess the physical and mental well-being of these patients as well as their psychological status, and to compare these parameters with those of a group of subjects having BD-IPMNs.
MATERIALS AND METHODS

Patients
Twenty-two consecutive patients with a recent diagnosis of MD-IPMN (12 patients, 4 males, and 8 females; mean age, 67.8 years; range, 33-84 years) or mixed-IPMN (10 patients, 4 males, and 6 females; mean age, 76.0 years; range, 66-85 years) of the pancreas admitted to our department in 2011 were enrolled in this study. An equal number of patients with BD-IPMNs comparable for sex and age (±5 years) and randomly extracted from our prospective database of IPMN patients were also studied (22 patients, 8 males, and 14 females; mean age, 70.1 years; range, 30-85 years). The epidemiological and clinical data of the 44 patients studied are reported in Table 1 . For the purpose of the study, the patients having MD-IPMNs and mixed-IPMNs were treated as a single group because their follow-up and treatment were similar in accordance with the various guidelines. 4 In addition, patients who underwent pancreatic resection during the follow-up period were excluded from filling out the questionnaires because surgery may have changed the QoL as has previously been reported. 5 
Ethics
The study was approved by the Senior Staff Committee of the Department of Digestive System of the University of Bologna and was carried out in accordance with the Helsinki Declaration of the World Medical Association. All study participants gave informed consent.
Clinical and Imaging Data
All patients were followed according to the suggestions of the Sendai criteria available at the time at which the study was designed. 1 Magnetic resonance imaging and magnetic resonance cholangiopancreatography were carried out at baseline as well as in the follow-up period, and endoscopic ultrasonography was used when considered necessary.
Regarding BD-IPMNs, the size of the cystic lesion, the size of the main pancreatic duct, and the presence of mural nodules within the cyst were recorded. For the purpose of the study, only the annual imaging study was taken into consideration. During the clinical follow-up study, the appearance of symptoms (ie, pancreatitis) attributable to the cystic lesion, the presence of intramural nodules, a cystic size greater than 30 mm, and dilation of the main pancreatic duct (greater 10 mm) were recorded.
For MD-IPMNs and mixed-IPMNs, there were no changes in either the clinical or the therapeutic approaches between the Sendai and the Fukuoka recommendations, 1, 6 and surgery was recommended for this type of patient when no contraindications were present. Finally, all patients were fully informed about the risk of their pancreatic disease, especially those with MD/mixed-IPMNs, and our suggested management, observational or surgical, was evaluated and discussed with each patient and his/her caregiver. Twelve items of the GHQ-12 measure current mental health. [8] [9] [10] The score ranges from 0 to 12; a score from 0 to 4 designates subjects having nonpsychotic psychiatric disorders, whereas a score greater than 4 indicates subjects affected by nonpsychotic psychiatric disorders. 11 The STAI 12 and the BDI-II 13 were used to evaluate anxiety disorders and depressive syndromes; the STAI contains 40 items generating 2 scales ranging from 20 to 80, and high scores represent a high level of anxiety. 12, 14 The BDI-II 13 is made up of 21 items that assess the severity of depressive symptoms over the 2 weeks before its use. Each item is rated on a 4-point scale (0-3) with total scores ranging from 0 to 63; scores greater than 28 indicate severe depression, scores ranging from 20 to 28 indicate moderate depression, scores ranging from 14 to 19 are compatible with mild depression, and, finally, scores equal to or less than 13 suggest an absence of depression. 13, 15 All patients studied were fluent in the Italian language, and the questionnaires were administered according to the recommendations of the user manuals. 7, [14] [15] [16] All the questionnaires were administered once a year for 3 consecutive years: on admission to the study, and 1 and 2 years thereafter.
Statistics
The descriptive statistics applied were mean (standard deviation [SD] ) and ranges as well as absolute and relative frequencies. One-way analysis of variance, the Pearson χ 2 test, and the Wilcoxon test were also applied where appropriate. All statistical evaluations were carried out by running SPSS version 13.0 for Windows (SPSS Inc, Chicago, Ill). Two-tailed P values less than 0.05 were considered statistically significant.
The sample size originated from the suggestions of the SF-12 questionnaire and the number of patients enrolled was adequate. 7 
RESULTS
Clinical and Imaging Data at Basal Evaluation and During the Follow-up Period
As shown in Table 1 , among the clinical variables considered, the frequency of MD/mixed-IPMN patients who continued to consume alcohol after the diagnosis was significantly higher as compared with BD-IPMN patients; the duration of alcohol drinking was much longer in the MD/mixed-IPMN group with respect to the BD-IPMN group. Main duct or mixed type IPMN patients also had more frequent abdominal discomfort and episodes of acute pancreatitis than patients with BD-IPMNs. Regarding the educational level, MD/mixed-IPMN patients had significantly lower educational levels as compared with BD-IPMN patients.
Eight patients with MD/mixed-IPMNs were resected (pancreatic head resection was carried out in 2, distal pancreatectomy in 3, and total pancreatectomy in 3), and the pathology was compatible with high-grade dysplasia in 5 patients and moderate dysplasia in the remaining 3; of the remaining patients, 12 were not operated on because of severe comorbidities and 2 because they refused surgery. The mean (SD) size of main pancreatic duct in nonoperated MD/mixed-IPMNs patients increased during the follow-up period, 12.3 (17.0) mm at basal evaluation, 13.8 (22.1) mm at second evaluation, and 29.5 (33.2) mm at the third evaluation, and this increase in size was not statistically significant (P = 0.573). Two patients in this group died from progression of the disease, and both were in the group of nonoperated on patients.
Regarding patients with BD-IPMNs, the cyst was localized at the head of the pancreas in 4 patients (18.2%), in the body in 1 (4.5%), in the tail in 2 (9.1%), in the head and the body in 6 (27.3%), and diffuse throughout the gland in 9 (40.9%). At entry into the study, the mean (SD) size of the major lesion was 17.9 (9.0) mm (range, 5-38 mm); in the follow-up period, the mean (SD) size of the lesions remained substantially stable, 16.8 (8.6) (range, 5-38 mm) at the second evaluation at 1 year after enrollment, whereas it decreased at the third evaluation 2 years after enrollment, 13.0 (6.2) (range, 5-19). These differences among the 3 evaluations were statistically significant (P = 0.032). Seven BD-IPMN patients were operated on: 6 had pancreatic resections, and 1 had a laparoscopic enucleation of the cysts. The pathology was compatible with high-grade dysplasia in 3 patients, moderate dysplasia in 2, and mild dysplasia in 2. Two patients died during the 2-year follow-up period from causes unrelated to pancreatic disease: 1 from hepatic cirrhosis and 1 from pulmonary embolism after orthopedic surgery.
QoL Questionnaires at Basal Evaluation and During the Follow-up Period
Of the 44 patients who agreed to respond to the questionnaire, 9 (20.5%) completed the study. Of the remaining 35 patients, 7 refused to complete the questionnaires, 15 had a pancreatic resection and dropped out of the study after surgery, 4 died, and 9 were lost to follow-up.
At basal evaluation, the SF-12 questionnaire administered to the 44 patients showed that the values of the PCS-12 and MCS-12 scores were similar between the 2 groups of patients studied and representative of a relatively good physical and mental QoL ( Table 2) .
The STAI questionnaires showed that anxiety was similar in the 2 groups of patients studied (Table 2) ; the GHQ-12 and the BDI-II scores were also similar between the 2 groups of patients studied (Table 3) . Taking into consideration all the results of the questionnaires used, no differences were found between BD-IPMNs and MD/mixed-IPMNs at the 1-year and the 2-year evaluations (Tables 2, 3) .
As shown in Tables 2 and 3 , the PCS-12 and MCS-12 scores as well as both the STAI-Y1 and the STAI-Y2 scores, and the GHQ-12 and the BDI-II scores did not change in the 2 subsequent evaluations in the MD/mixed-IPMN and in the BD-IPMN patients.
The possible relationships between the demographic and the clinical characteristics, and the QoL scores in the 2 groups of patients with IPMNs (Table 4) were also explored. Of the variables taken into consideration, retired patients having MD/mixed-IPMNs had more symptoms of depression according to the BDI-II score. In a similar manner, retired patients having BD-IPMNs had more nonpsychotic disorders than those working, according to the GHQ-12 questionnaire. In patients with BD-IPMNs, the mean (SD) STAI-Y2 score was significantly higher in single, 49.3 (10.7), than in married, 38.0 (9.0) (P = 0.018).
DISCUSSION
The author recently reported that the well-being of patients with BD-IPMNs is not different from that of the reference Italian population. 2 However, no data regarding QoL have been evaluated for those patients having MD/mixed-IPMNs. It is well known that experts suggest that resection is indicated in these latter 2 groups owing to the high risk of having severe dysplasia or a pancreatic adenocarcinoma, 4 and it is possible that their QoL may worsen after receiving complete information. Thus, our aim was to evaluate, over a 2-year period, the QoL of patients recently identified as having MD/mixed-IPMNs at the time of diagnosis and in the 2 years of follow-up. In addition, the associated epidemiological and clinical variables of these patients were also recorded. The well-being of these patients was also compared with those having BD-IPMNs, matched for sex and age, who were used as a control population.
Regarding the socioeconomic status, an interesting result is the much higher and significant prevalence of BD-IPMN patients who had either a university or high school degree (50%) as compared with 18% of those having MD/mixed-IPMNs. The reason for this finding is not clear, but additional studies are necessary to explain this difference.
Among the clinical variables considered, the frequency of MD/mixed-IPMN patients who continued to consume alcohol after the diagnosis was significantly higher as compared with BD-IPMN patients, and the duration of alcohol drinking was much longer in the MD/mixed-IPMN group with respect to the BD-IPMN group. In addition, MD/mixed-IPMN patients also had more frequent abdominal discomfort and episodes of acute pancreatitis than patients with BD-IPMNs. From a clinical point of view, the presence of a long duration of alcohol assumption and the presence of abdominal discomfort or previous episodes of acute pancreatitis sometimes make the differential diagnosis between MD/mixed-IPMNs and chronic pancreatitis difficult. 17 It should also be noted that only 8 patients with MD/mixedIPMNs were resected, and the pathology was compatible with high-grade dysplasia in 5 patients. The surgical approach was only indicated in less than 50% of patients because advanced age and the presence of comorbidities contraindicated pancreatic resection. Most importantly, in nonresected patients, only 2 died from progression of the disease, and both were in the group of nonoperated on patients. This confirmed the fact that this type of pancreatic lesion is slow-growing.
Regarding the main aim of this study, that is, the QoL of patients with MD/mixed-IPMNs, it was found that, at basal evaluation, the values of the PCS-12 and MCS-12 scores calculated on the basis of SF-12 were similar between the 2 groups of patients studied and were representative of a relatively good physical and mental QoL. The scores of the psychological questionnaires administered at basal evaluation also demonstrated that anxiety and depression were similar in the 2 groups of patients studied. Of importance, taking into consideration all the results of the questionnaires used, no differences were found between BD-IPMNs and MD/mixed-IPMNs at the 1-year and the 2-year evaluations. These findings are compatible with the fact that IPMN lesions are asymptomatic in most patients and are slow-growing lesions. In fact, pain in pancreatic disease is the major factor capable of worsening the QoL of patients. 18, 19 The possible relationships between the demographic and the clinical characteristics, and the QoL scores in the 2 groups of patients with IPMNs was also explored, and it was found that the STAI-Y2 score was significantly higher in single than in married BD-IPMN patients. This is a new finding that should be better evaluated in the future. The reason for this is not clear, but it has been reported that the poor relationship between spouses repeats the lack of closeness to parents experienced in adolescence, thus leading to a deficiency in establishing close interpersonal relationships within the family. 20 In addition, retired people having MD/ mixed-IPMNs had more symptoms of depression according to the BDI-II score and retired patients having BD-IPMs also had more nonpsychotic disorders than those who were working, according to the GHQ-12 questionnaire. These data are in agreement with previous reports 21, 22 ; symptoms of depression often go unrecognized and are undertreated in this group of patients. Older adults should be encouraged to maintain normal employment for as long as possible before retirement. 23 The main limitation of the study is the low number of subjects having MD/mixed-IPMNs who completed the study; it is well understandable that it is difficult to collect sufficient number of patients with MD/mixed-IPMNs in a single center, and this is owing to the fact that most of these were operated on early according to the suggestions of the guidelines 1 ; however, we believe that a multicenter study that will be carried-out in the future may confirm our present data.
In conclusion, this is the first time that the well-being of patients having MD/mixed-IPMNs of the pancreas has been evaluated. The results confirmed our previous observations regarding BD-IPMNs, 2 namely, these lesions are different from other benign pancreatic diseases, both acute 18 and chronic. 19 Knowledge of patient-reported outcome in patients with MD/mixed-IPMNs of the pancreas provides important information regarding the longterm effects of well-being and is also important in identifying potential adjustment problems in a low percentage of patients, especially in those having psychiatric problems who may benefit from anxiolytic or antidepressant drugs. 24 
